Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 1,490 shares at $14.79 ($22K) on 2026-04-28, disclosed to the SEC on 2026-04-30.
Open-market sale of $22k RLAY by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-01-29 | $167K | — | Filing → |